aprindine has been researched along with Long QT Syndrome in 1 studies
Aprindine: A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sasaoka, S | 1 |
| Matsui, T | 1 |
| Hane, Y | 1 |
| Abe, J | 1 |
| Ueda, N | 1 |
| Motooka, Y | 1 |
| Hatahira, H | 1 |
| Fukuda, A | 1 |
| Naganuma, M | 1 |
| Hasegawa, S | 1 |
| Kinosada, Y | 1 |
| Nakamura, M | 1 |
1 other study available for aprindine and Long QT Syndrome
| Article | Year |
|---|---|
Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events.
Topics: Administration, Oral; Aprindine; Bepridil; Databases, Factual; Female; Humans; Long QT Syndrome; Mal | 2016 |